Startup with bold goal to establish digital biomarkers for neurological disease diagnosis wins $25M
NeuraLight just raised $25 million in its bid to create new, digital endpoints that can be used by clinicians and researchers to objectively measure neurological conditions with the ultimate goal - still several years away - to have the company's technology serve as the gold standard for neurological evaluation.